Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients
Arthritis Research & Therapy2014Vol. 16(2), pp. R63–R63
Citations Over TimeTop 10% of 2014 papers
Michael S. Hershfield, Nancy J. Ganson, Susan J. Kelly, Edna Scarlett, Denise Jaggers, John S. Sundy
Abstract
ClincalTrials.gov identifier: NCT00111657.
Related Papers
- Gout and its comorbidities.(2010)
- → Sensitivity and specificity of dosing alerts for dosing errors among hospitalized pediatric patients(2014)29 cited
- → Efficacy of nivolumab four-weekly dosing schedule based on body weight(2019)10 cited
- → Hyperuricaemia and gout(2020)1 cited
- → The Impact of Role of Pharmacists in Renal Dosage Adjustment Program on Renal Drug Dosing Errors: A Quasi-Experimental Study(2021)1 cited